You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antineoplastic agents/*adverse events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reporting of AdVerse Events Associated With AnTicAncerRapy

Recruiting
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 4, 2021

Ocular Adverse Events in Neovascular Agerelated Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Reporting of Cardio-vascular Adverse Events With Antineoplastic

Unknown status
  • Cardiac Disease
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital,Department of Pharmacology, CI
Sep 2, 2019

Severe Checkpoint Inhibitor Pneumonitis Trial in Beijing (Corticosteroids, Corticosteroids and Ruxolitinib)

Recruiting
  • Severe Checkpoint Inhibitor Pneumonitis
  • Beijing, Beijing, China
    Department of Respiratory Medicine, Peking Union Medical College
Jun 12, 2023

Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

Recruiting
  • Inflammatory Disease
  • +2 more
  • Infliximab subcutaneous
  • Immunosuppressive Agents
  • Amsterdam, North Holland, Netherlands
    Amsterdam UMC AMC
Sep 27, 2023

Responsible Side Effects Management in Oncology

Completed
  • Pharmacovigilance
  • +2 more
    • Zagreb, Croatia, Europe, Croatia
      UHC Sestre milorsdnice
    Nov 4, 2020

    CIPN and it's Impact on Quality of Life in Patients Receiving

    Not yet recruiting
    • Chemotherapy-induced Peripheral Neuropathy
      • (no location specified)
      Apr 24, 2023

      Anticancer Vigilance Of Cardiac Events in Metastatic Colorectal

      Unknown status
      • Colorectal Cancer Metastatic
      • Antineoplastic Agents
      • Caen, Normandy, France
        CHU Caen
      Apr 19, 2019

      Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

      Recruiting
      • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
      • Columbus, Ohio
      • +9 more
      Aug 1, 2022

      Reporting of Antibody-Drug Conjugate Associated Sepsis-related

      Completed
      • Sepsis (SMQ)
      • +2 more
      • Antibody-Drug Conjugate
      • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
      • Changsha, Hunan, China
        Central South University
      Jun 19, 2022

      Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Myelodysplastic Syndromes
      • Marina Del Rey, California
      • +35 more
      Mar 11, 2022

      Non-Hodgkin Lymphoma Trial in Worldwide (Epcoritamab, Lenalidomide, Ibrutinib)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Tucson, Arizona
      • +81 more
      Jan 25, 2023

      Solid Tumor, Adult Trial in Providence, Nashville (DF6215)

      Not yet recruiting
      • Solid Tumor, Adult
      • Providence, Rhode Island
      • +1 more
      Oct 25, 2023

      Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

      Not yet recruiting
      • Advanced Cancer
      • +16 more
      • Fosifloxuridine Nafalbenamide
      • +3 more
      • Birmingham, United Kingdom
      • +3 more
      Feb 1, 2023

      Febrile Neutropenia, Solid Tumor, Hematologic Tumors Trial in Clamart, Le Kremlin-Bicêtre (NEUTROSIS)

      Completed
      • Febrile Neutropenia
      • +2 more
      • NEUTROSIS
      • Clamart, France
      • +2 more
      May 2, 2022

      Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)

      Recruiting
      • Chemotherapy-induced Nausea and Vomiting (CINV)
      • Granisetron Transdermal Delivery System
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Apr 19, 2022

      Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

      Recruiting
      • Cancer
      • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
      • Jinan, Shandong, China
        Shandong Provincial Qianfoshan Hospital
      Jul 18, 2022

      Hematologic Malignancy Trial in Bologna

      Recruiting
      • Hematologic Malignancy
        • Bologna, Italy
          Programma Dipartimentale Terapie Cellulari Avanzate
        Apr 17, 2023

        Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

        Recruiting
        • Advanced Pancreatic Cancer
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Oct 17, 2022

        Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

        Not yet recruiting
        • Female Breast Cancer
        • Hormonal Antineoplastics
        • Chemotherapy drug
        • Sohag, Egypt
          amal Ali
        Feb 23, 2023

        Solid Tumor Trial in United States (drug, combination product, biological)

        Recruiting
        • Solid Tumor
        • Pembrolizumab
        • +2 more
        • Sacramento, California
        • +6 more
        Jan 3, 2023

        Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

        Not yet recruiting
        • Urothelial Carcinoma
        • +7 more
        • Jelmyto (mitomycin) for pyelocalyceal solution
        • (no location specified)
        May 22, 2023

        HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

        Recruiting
        • HER2 Positive Early Breast Cancer
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center Shanghai, China, 200032
        Jun 6, 2023

        Contrast Enhancement in Magnetic Resonance Imaging, CNS Pathology Trial in Worldwide (Gadoquatrane (BAY1747846), Gadobutrol,

        Not yet recruiting
        • Contrast Enhancement in Magnetic Resonance Imaging
        • Central Nervous System Pathology
        • Gadoquatrane (BAY1747846)
        • +3 more
        • Indian Wells, California
        • +90 more
        Jun 25, 2023